Long-term use of ART in African women of reproductive age

Abstract

There is strong evidence that antiretroviral therapy (ART) for cisgender women of reproductive age living with HIV reduces vertical HIV transmission1 and improves women's health and survival.2 However, there is a dearth of research on the long-term (≥5 years) effects of ART in reproductive-age women who started ART during pregnancy.